Gain-of-function of WNK1 and WNK4 caused by gene mutation leads to an autosomal-dominant disease pseudohypoaldosteronism type 2 (PHA2) featured by hypertension, hyperkalemia and hyperchloremic metabolic acidosis [2,3]. The gene discussed is WNK1; the disease is pseudohypoaldosteronism type 2.